(AOF) – Mauna Kea Technologies announces the opening in Rome of the first Italian center of excellence for the use of its Cellvizio device in the identification and treatment of food intolerances in adults suffering from irritable bowel syndrome . The Cellvizio Food Intolerance Test (C-FIT) is now used by Dr. Alberto Larghi, gastroenterologist at UPMC Salvator Mundi International Hospital in Rome. Italy thus becomes the third country to have such a center after the Metrodora Institute in the United States and several sites in Germany.
© 2024 Agence Option Finance (AOF) – All reproduction rights reserved by AOF. AOF collects its data from the sources it considers the safest. However, the reader remains solely responsible for their interpretation and use of the information made available to them. The reader must therefore hold AOF and its contributors harmless from any claim resulting from this use. Agence Option Finance (AOF) is a brand of the Option Finance group
Did you like this article ? Share it with your friends using the buttons below.
